Enterotoxemia, a disease that affects domestic ruminants, is caused mainly by the epsilon toxin from Clostridium perfringens type D. Its eradication is virtually impossible, control and prophylaxis are based on systematic vaccination of herds with epsilon toxoids that are efficient in inducing protective antibody production. The use of recombinant toxins is one of the most promising of these strategies. This work evaluates the potency of a Cl. perfringens type D epsilon toxoid expressed by Escherichia coli administered to goats, sheep, and cattle. The etx gene was cloned into the pET-11a plasmid of E. coli strain BL21 to produce the recombinant toxin. Rabbits (n=8), goats, sheep, and cattle (n=5 for each species) were immunized with 0.2mg of the insoluble recombinant protein fraction to evaluate vaccine potency of the epsilon toxoid studied. Antibody titers were 40, 14.3, 26, and 13.1 IU/mL in the rabbit, goat, sheep, and cattle serum pools, respectively. The epsilon toxoid produced and tested in this work is adequate for immunization of ruminants against enterotoxemia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2010.07.046 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The efficacy of egg albumin nanoparticles adjuvanted Clostridium perfringens type D toxoid vaccine in rabbits.
Braz J Microbiol
December 2024
Institute of Microbiology, Faculty of Veterinary Science, University of Agriculture, Faisalabad, 38040, Pakistan.
Epsilon toxin (ETX) is an exotoxin produced by Clostridium perfringens type D that induces enterotoxaemia or necrotic intestinal infection in small ruminants and bovine. Immunization is an essential element in preventing the spread of infectious diseases. In recent literature, nanocarriers have exhibited the capacity to deliver protection, stability, and regulated distribution properties to protein-based antigens.
View Article and Find Full Text PDFBackground: The complex and expensive processes involved in the production of current clostridial toxoid vaccines require the design of new methods. The aim of this study was to introduce single and combined nontoxic mutants of Clostridium perfringens epsilon toxin (ETX) into the vaccine production.
Methods: Antigenic properties, amino acid sequence, physicochemical characteristics, stability, and protein structure of individual and combined ETX mutants were investigated with bioinformatics software.
Correction: Khan et al. Oral Immunization of Chickens with Probiotic Constitutively Expressing the α-β2-ε-β1 Toxoids to Induce Protective Immunity. 2022, , 698.
Vaccines (Basel)
October 2024
College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
Article Synopsis
- The authors are requesting corrections to various parts of a previously published paper.
- These corrections may involve changes in data, interpretations, or conclusions.
- The aim is to clarify or rectify any inaccuracies in the original publication.
Protection efficacy and immunogenicity of Clostridium chauvoei proteins as a subunit blackleg vaccine or an adjuvant for Clostridium perfringens epsilon toxoid.
Toxicon
November 2024
Department of Microbiology, Islamic Azad University, Tehran North Branch, Tehran, Iran.
Potential application of Clostridium chauvoei proteins was studied as a subunit blackleg vaccine or a biological adjuvant for Clostridium perfringens epsilon toxoid vaccine. Extracellular and cell surface proteins were extracted from C. chauvoei culture, and their protective efficacy was evaluated by potency test in guinea pigs.
View Article and Find Full Text PDFImmunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep.
Anaerobe
October 2024
Programa de Pós-Graduação em Veterinária, Faculdade de Veterinária, Universidade Federal de Pelotas (UFPEL), Pelotas, RS, Brazil; Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas (UFPEL), Pelotas, RS, Brazil.
Introduction: Producing commercial bacterins/toxoids against Clostridium spp. is laborious and hazardous. Conversely, developing prototype vaccines using purified recombinant toxoids, though safe and effective, is both laborious and costly for application in production animals.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!